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Summary
INTRODUCTION: Oropharyngeal dysphagia (OD) is often
observed in critically ill patients. In most affected patients
OD persists throughout hospital stay and negatively im-
pacts on clinical outcomes. Here we systematically ex-
plore routine clinical practice standards for recognition/
screening, diagnosis and treatment of OD in accredited
Swiss ICUs.
METHODS: An online, 23-item questionnaire-based sur-
vey was performed to investigate current standards of
care for OD in Switzerland (DICE). All (n = 49) accredited
Swiss teaching hospitals providing specialist training for
adult intensive care medicine were contacted. Senior in-
tensivists were interviewed on how they would screen for,
diagnose and treat OD in the ICU.
RESULTS: The total response rate was 75.5%, with in-
formation available on all tertiary care academic centres.
67.6% (25/37) of institutions stated that they have es-
tablished standard operating procedures for OD using a
mostly sequential diagnostic approach (86.5%, 32/37). In
75.7% (28/37) of institutions, OD confirmation is per-
formed without the use of instrumental techniques such
as flexible (or fibre-endoscopic) evaluation of swallowing
(FEES). Presumed key risk factors for OD were admission
for acute neurological illness, long-term mechanical ven-
tilation, ICU-acquired weakness and pre-existing neuro-
logical disease. Reported presumed OD-related compli-
cations typically include aspiration-induced pneumonia,
increased rates of both reintubation and tracheostomy and
increased ICU readmission rates.
CONCLUSIONS: Many Swiss ICUs have established
standard operating procedures, with most using sequen-
tial clinical approaches to assess ICU patients at risk of
dysphagia. OD confirmation is mostly performed using
non-instrumental techniques. In general, it appears that
awareness of OD and ICU educational curricula can be
further optimised.
Trial registration number: NCT 03487510
Key words: dysphagia, critical illness, ICU, swallowing
dysfunction, deglutition disorder, sepsis
Introduction
Oropharyngeal dysphagia (OD) and its associated conse-
quences (e.g. aspiration-induced pneumonia) can often be
observed in intensive care units (ICUs) [1, 2]. Until re-
cently, the incidence of dysphagia in general ICU popu-
lations was unclear, with many studies limited by design,
sample size or inclusion of heterogenous patient cohorts
[3–8]. Recent data from a large-scale prospective study in
a non-selected (i.e. mixed medical/surgical) ICU popula-
tion demonstrate an incidence of post-extubation dyspha-
gia (PED) on the ICU of 12.4% (18% of emergency ad-
missions affected), with dysphagia mostly persisting until
hospital discharge and an excess 90-day mortality rate of
9.2% [9]. In addition, data hint at a high economic burden
of dysphagia on both the ICU sector and public health care
systems [9, 10].
Importantly, there is currently a lack of standardised pro-
tocols to assess OD. Different approaches to dysphagia as-
sessment in the ICU, e.g. both screening for OD risk and
following this with confirmatory testing, have been pro-
posed. Confirmatory tests differ regarding whether they are
performed using non-instrumental, i.e. clinical, approach-
es by dysphagia specialists ([11–29]; reviewed in [30]), or
using instrumental measures [31–44], e.g. flexible endo-
scopic evaluation of swallowing (FEES) or video-fluoro-
scopic swallowing study (VFSS) [2]. Importantly, aware-
ness of OD in the ICU regarding screening for, diagnosing
or managing it may be limited, and an accepted standard of
care for OD assessment in ICU patients is currently lack-
ing [45, 46]. In light of the fact that dysphagia is a com-
monly observed clinical problem on the ICU and the lack
of an internationally accepted clinical standard, the present
survey (DICE) aims to explore the current clinical standard
of care for OD management in Switzerland. This includes
dysphagia recognition, screening, diagnosis and treatment
in Swiss ICUs.
Material and methods
A 23-item internet-based questionnaire (see appendix 1)
was used to systematically record the current screening, di-
agnosis and treatment approaches for OD on Swiss ICUs
(DICE). This questionnaire was developed based on our
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own institutional experience, established internal standard
operating procedures, and data presented in the DYnAM-
ICS study [9] and other recent publications on dysphagia
[2, 30]. All 49 Swiss ICUs accredited by the Swiss Institute
for Continuous Education for ICU training in adults were
contacted and asked about their local clinical practice stan-
dards. Units are categorised as Au, A, B and C according
to their accreditation levels (Au being tertiary care aca-
demic teaching hospitals). Further details are listed else-
where (www.siwf-register.ch). DICE was performed from
11/2017 until 03/2018. Chief physicians and/or senior ICU
specialists were invited to participate and complete the
questionnaire. The 49 accredited Swiss ICUs include seven
tertiary academic centres (Au). These provide care for
mixed medical/surgical populations (n = 3), strictly sur-
gical (n = 2) or strictly medical (n = 2) patient cohorts.
The remaining 42 institutions are categorised as A-level
(n = 10), B-level (n = 11) or C-level institutions (n = 21).
They provide intensive care for mostly mixed patient pop-
ulations. No specific hypothesis was used. The intension
was to investigate the current (national) standard of ICU
care. Ethics approval for DICE-Swiss was waived by the
Ethics Committee on Human Research (Kantonale Ethik-
Kommission, KEK, Bern, Switzerland).
Statistical analysis
Descriptive analyses were used to compare results reported
as counts or percentages. For categorical data, Fishers’ ex-
act test was used to compare nominal data between groups
with small sample sizes. Significance was assigned to cas-
es where a two-sided p-value was <0.05. Statistical analy-
sis was performed using MedCalc 16.4.3 Software (Med-
Calc, Mariakerke, Belgium) and SPSS (IBM SPSS
Statistics, Version 25).
Results
Centre characteristics and response rates
Thirty-seven registered Swiss ICUs participated in this na-
tionwide investigation (total response rate of 75.5%). All
(n = 7, 100%) accredited tertiary care academic university
hospitals (Au-units) participated in the survey. Duplicate
reports were returned by two institutions, resulting in only
the first report being analysed, as pre-defined. Data were
available from n = 9/10 (90%) of the A-units, n = 10/
11 (91%) of the B-units, and n = 11/21 (52%) of the C-
units (table 1). Most ICUs were interdisciplinary (med-
ical/surgical, n = 26/37, 70.3%), followed by mixed med-
ical or mixed surgical units (both n = 4/37, 10.8%). Two
neurological units and one cardiovascular unit were in-
cluded (table 1). The total number of ICU beds per unit
ranged from ≤6 beds (n = 1) to 7–12 beds (n = 21/37,
56.8%), and ≥30 beds (n = 3). The number of patients treat-
ed per year ranged from <750 patients (n = 4/37, 10.8%),
751–1500 patients (n = 20/37, 54.1%), 1501–2250 patients
(n = 6/37, 16.2%), 2251–3,000 patients (n = 5/37, 13.5%)
to 3001–3750 patients (n = 2/37, 5.4%).
Screening approaches
All participating units considered swallowing disorders a
significant clinical problem in the ICU. Approximately
68% of institutions have a standard operating procedure
(SOP) for OD (n = 25/37). Three units planned to imple-
ment an SOP in the near future, whereas nine units (n = 9/
37, 24.3%) had not installed an SOP and had no plan to in-
stall one in the near future (see appendix 2). Twenty-sev-
en percent (n = 10/37) of institutions systematically screen
all ICU patients, whereas in the majority (73%, n = 27/37)
of units, dysphagia-related risk is assessed on an individ-
ual basis (table 2). Five units assess all potentially affected
ICU patients (table 2).
Frequency analysis showed that in 17 out of 37 units (46%,
multiple answers analysis, data not shown), OD risk was
assessed in four groups of patients, i.e. in ICU patients post
extubation/decannulation, in patients with known baseline
neurological disease, in cases of pre-existing swallowing
disorders, and in patients with clinical signs suggesting a
deglutition disorder. When analysing these categories sep-
arately, ICU patients post extubation and patients with clin-
ical signs indicating dysphagia are screened with the high-
Table 1: Centre characteristics.
Training level
Au
(n = 7/7)*
A
(n = 9/10)
B
(n = 10/11)
C
(n = 11/21)
n (%) n (%) n (%) n (%)
Type of ICU Interdisciplinary (mixed medical/surgical) 3 (42.9) 6 (66.7) 9 (90) 8 (72.7)
Mixed medical 2 (28.6) 1 (11.1) 1 (9.1)
Mixed surgical 2 (28.6) 2 (22.2)
Neurological 1 (10) 1 (9.1)
Cardiovascular 1 (9.1)
Beds per ICU 1–6 1 (9.1)
7–12 1 (14.3) 2 (22.2) 8 (80) 10 (90.9)
13–18 1 (14.3) 4 (44.4) 1 (10)
19–24 2 (28.6) 3 (33.3) 1 (10)
>30 3 (42.9)
Patients per year <750 1 (10) 3 (27.3)
751–1500 2 (28.6) 4 (44.4) 7 (70) 7 (63.6)
1501–2250 1 (14.3) 3 (33.3) 2 (20)
2251–3000 3 (42.9) 1 (11.1) 1 (9.1)
3001–3750 1 (14.3) 1 (11.1)
* 49 accredited ICU training units were contacted initially (response rate 76%).
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est frequency (67.6%). This is followed by patients with
neurological deficits and patients with pre-existing swal-
lowing dysfunctions (62.2%).
Technical aspects regarding screening measures
The initial screening is performed by trained ICU nurses
in the majority (65%) of institutions, followed by other
nurses (n = 10/37, 27%), speech language therapists (SLT,
27%), physiotherapists (PT, 32%) and occupational thera-
pists (OT, 13.5%). In three units, screening is performed
by physicians (ICU physician in n = 2/37, 5.4%; ear-nose-
throat (ENT) physician n = 1/37, 2.7%). Initial screening
is mostly performed non-instrumentally using a bedside
swallowing evaluation (BSE, n = 13/37, 35.1%) or a water
swallow test (WST, n = 19/37, 51.4%). One unit reported
performing an instrumental approach (FEES) (n = 1/37,
2.7%). (See table 2.)
Incidence of OD in Swiss units
Estimated dysphagia frequency rates in ICUs ranged from
0–10% (n = 4/37, 11%) to 71–80% (2/37, 5.4%), with the
majority of units reporting an incidence between 11 and
20% or 21 and 30% (both n = 11/37, 30%).
Confirmatory testing for OD
Overall, 86.5% (32/37) of all units had established a se-
quential approach for dysphagia testing, i.e. a screening
procedure for OD risk assessment followed by a confirma-
tory test evaluating OD presence. In 91.9% (34/37), OD
diagnosis is established by a dysphagia specialist (either
SLT, PT or OT). In a minority of units (n = 2) this would
only be performed by a physician. One unit reported no
confirmatory assessment measures. Most units have ap-
pointed multiple team members to participate in OD con-
firmation. In detail, testing by SLTs was reported to occur
in 54.1% (n = 20/37), by PTs in 24.3% (n = 9/37), and
by OTs in 18.9% (n = 7/37) of institutions. OD confirma-
tion is performed by ICU physicians in 5.4% (n = 2/37)
and by ENT physicians in 43.2% (n = 16/37) of institu-
tions. BSE is the bedside clinical exam most commonly
used to establish a diagnosis (n = 23/37, 62.2%), followed
by FEES (24.3%, n = 9/37), which is performed mostly
by ENT physicians (n = 6/9, 66.7%). Diagnosis is estab-
lished by ICU physicians who do not have formal FEES
accreditation in 2.7% (n = 1/37) of institutions, and other
approaches are used in 5.4% (n = 2/37) of institutions. (See
table 2.)
Table 2: Responses regarding the screening, confirmation and treatment of dysphagia in all participating ICUs, as well as the methods used for assessing OD.
ICU responses All
(n = 37)
Au+A ICUs
(n = 16)
B+C ICUs
(n = 21)
p-Value
n % n % n %
Screening of which patients? All 5 13.5 2 12.5 3 14.3 1.00
Post extubation 25 67.6 12 75 13 61.9 0.49
With baseline neurodeficits 23 62.2 7 43.8 16 76.2 0.09
Pre-existing dysphagia 23 62.2 8 50 15 71.4 0.31
Clinical signs 25 67.6 10 62.5 15 71.4 0.73
Screening performed by? ICU nurse 24 64.9 11 68.8 13 61.9 0.74
Any nurse 10 27.0 4 25 6 28.6 1.00
SLT 10 27.0 4 25 6 28.6 1.00
PT 12 32.4 4 25 8 38.1 0.49
OT 5 13.5 2 12.5 3 14.3 1.00
ICU physician 2 5.4 2 9.5 0.50
ENT physician 1 2.7 1 4.8 1.00
How do you screen? FEES 1 2.7 1 4.8 1.00
BSE 13 35.1 5 31.3 8 38.1 0.74
WST 19 51.4 10 62.5 9 42.9 0.33
Test meal 1 2.7 1 4.8 1.00
Other 3 8.1 1 6.25 2 9.5 1.00
Confirmation of OD by? No confirmatory examination 1 2.7 1 4.8 1.00
SLT 20 54.1 9 56.3 11 52.4 1.00
PT 9 24.3 6 37.5 3 14.3 0.14
OT 7 18.9 2 12.5 5 23.8 0.67
ICU physician 2 5.4 2 9.5 0.50
ENT physician 16 43.2 8 50 8 38.1 0.52
Any nurse 1 2.7 1 6.25 0.43
Method for confirmation? Clinical evidence 4 10.8 4 19.0 0.12
BSE 23 62.2 10 62.5 13 61.9 1.00
FEES 9 24.3 5 31.3 4 19.0 0.46
other 1 2.7 1 6.25 0.43
Treatment for OD? NPO 9 24.3 6 37.5 3 14.3 0.14
Dietary modification 29 78.4 12 75 17 81.0 0.71
Tube feeding 18 48.6 7 43.8 11 52.4 0.74
Tracheostomy 8 21.6 6 37.5 2 9.5 0.06
Training 34 91.9 13 81.3 21 100.0 0.07
BSE = bedside swallowing evaluation; ENT = ear-nose-throat; FEES = flexible endoscopic evaluation of swallowing; ICU = intensive care unit; NPO = nil per os; OD = oropharyn-
geal dysphagia; OT = occupational therapist; PT = physiotherapist; SLT = speech and language therapist; WST = water swallow test; Fisher’s exact test was used for between-
group comparison (A level vs B/C level teaching hospitals).
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Therapeutic approaches to OD
The reported treatment approaches for OD highlighted two
main pillars of dysphagia management: dietary texture
modification (78.4%, 29/37) and swallowing training by
dysphagia specialists alongside functional therapy includ-
ing postural changes (91.9%, 34/37). Temporary nil per os
(NPO) was implemented in about a quarter of all partici-
pating units (24.3%, 9/37), with tube feeding required in
48.6% (n = 18/37) and tracheostomy required in 21.6% (n
= 8/37). The responses received suggest that electrical or
magnetic stimulatory techniques or any other artificial de-
vices are not used in any of the participating ICUs. (See
table 2.)
Risk factors for OD development and complications
The following suspected risk factors for OD were reported:
admission for neurological disease (94.6%, n = 35/37),
long-term (>5 days) mechanical ventilation/intubation
(86.5%, n = 32/37), presence of ICU-acquired weakness
(83.8%, n = 31/37), pre-existing neurological disease
(83.8%, n = 31/37), advanced age (59.5%, n = 22/37), post-
trauma conditions (59.5%, n = 22/37), use of sedatives
(51.4%, n = 19/37), patients with initial sepsis (40.5%, n
= 15/37), feeding tube in situ (40.5%, n = 15/37), previous
intubation (37.8%, n = 14/37), use of neurotropic medica-
tions (37.8%, n = 14/37), use of muscle relaxants (35.1%,
n = 13/37), high cumulative amount of opioids (32.4%, n =
12/37), emergency admission (10.8%, n = 4/37) and pres-
ence of metabolic disorders (10.8%, n = 4/37) (table 3).
A significant impact of OD on mid- or long-term mortality
was assumed in nearly all participating ICUs (n = 33/37,
89.2%). Dysphagia was considered a factor which pro-
longs ICU stay (81.1%, n = 30/37) and increases total in-
hospital treatment costs (97.3%, n = 36/37). Complications
observed in the ICU include aspiration-induced pneumo-
nia (97.3%, n = 36/37), increased reintubation (70.3%, n
= 26/37) and readmission (59.5%, n = 22/37) rates, need
for tracheostomy (59.5%, n = 22/37), decannulation failure
(51.4%, n = 19/37) and malnutrition (40.5%, n = 15/37).
51.4% (n = 19/37) of units stated that awareness of OD on
the ICU should be improved. (See table 3.)
Discussion
Previous data demonstrate that OD presents in many ICU
patients, is associated with increased morbidity, and neg-
atively impacts on mid-term survival. OD was an inde-
pendent predictor of mortality in the DYnAMICS study,
Table 3: Responses regarding the presumed risk factors, complications, suspected impact on mortality, prolongation of ICU LOS, in-hospital costs and awareness of dysphagia
in participating ICUs.
ICU responses All
(n = 37)
Au+A ICUs
(n = 16)
B+C ICUs
(n = 21)
p-Value
n % n % n %
Presumed risk factors? Age 22 59 9 56.3 13 61.9 0.75
Emergency admission 4 11 2 12.5 2 9.52 1.00
Metabolic disorder 4 11 1 6.25 3 14.3 0.62
Neurological disease 35 95 16 100 19 90.5 0.50
Trauma 22 59 10 62.5 12 57.1 1.00
Sepsis 15 41 6 37.5 9 42.9 1.00
ICU AW 31 84 16 100 15 71.4 0.03
Pre-existing neurodeficits 31 84 14 87.5 17 81 0.68
Intubation 14 38 7 43.8 7 33.3 0.73
Long-term intubation 32 86 12 75 20 95.2 0.14
Feeding tube 15 41 6 37.5 9 42.9 1.00
Sedatives 19 51 8 50 11 52.4 1.00
Muscle relaxants 13 35 5 31.3 8 38.1 0.74
Opioids 12 32 6 37.5 6 28.6 0.73
Neurotropic medication 14 38 6 37.5 8 38.1 1.00
Presumed complications? Pneumonia 36 97 15 93.8 21 100 0.43
Sepsis 13 35 5 31.3 8 38.1 0.74
Readmission 22 59 10 62.5 12 57.1 1.00
Re-intubation 26 70 11 68.8 15 71.4 1.00
Tracheostomy 22 59 12 75 10 47.6 0.18
Decannulation failure 19 51 6 37.5 13 61.9 0.19
Malnutrition 15 41 5 31.3 10 47.6 0.50
OD impact on mortality? Yes 33 89 14 87.5 19 90.5 1.00
No 4 11 2 12.5 2 9.52
OD prolongs ICU LOS? Yes 30 81 13 81.3 17 81 1.00
No 6 16 3 18.8 3 14.3
Undecided 1 2.7 0 1 4.76
OD increases costs? Yes 36 97 16 100 20 95.2 1.00
No 1 2.7 0 1 4.76
Improve OD awareness? Yes 19 51 9 56.3 10 47.6 0.89
No 15 41 6 37.5 9 42.9
Undecided 3 8.1 1 6.25 2 9.52
ICU = intensive care unit; LOS = length of stay; OD = oropharyngeal dysphagia Fisher’s exact test was used for between-group comparison (A level vs B/C level teaching hospi-
tals).
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showing an excess 90-day mortality of +9.2% [9]. With in-
creasing awareness of the associated socio-economic con-
sequences, we investigated the current clinical practice
standards in Swiss ICUs. In DICE, we observed that most
ICUs have established internal standard operating proce-
dures for OD, and that initial screening is performed at
the bedside by nurses, followed by OD confirmation using
non-instrumental methods (a sequential approach).
In this survey, estimates of OD incidence rates varied
widely. Different responses are expected based on personal
experience, and the rather wide range of variation may the-
oretically be related to differences between the institutions
(e.g. increased OD rates in neuro-ICU units). Nevertheless,
there was also a wide range of estimated OD incidence
rates for units treating mixed populations of critically ill
patients. It seems tempting to speculate that this may be
related to the fact that most units have not installed a sys-
tematic assessment of all potentially affected ICU patients.
In DICE, we found that in 24.3% of the participating in-
stitutions there is currently no SOP for OD management in
place, and a minority (13.5%) screen all potentially affect-
ed ICU patients.
Presumed key consequences of OD included aspiration-in-
duced pneumonia (97.3%). In this context, it may be im-
portant to note that mounting evidence (e.g. in stroke pa-
tients) shows that early identification of OD may reduce
rates of pneumonia [47]. This evidence may support the
screening of potentially affected ICU patients. Further-
more, evidence also shows an association between a failure
to screen for dysphagia and subsequent adverse patient
outcomes, with increased disability, a higher rate of dis-
charge to a long-term care facility, and adverse outcomes
up to 365 days post initial hospitalisation [48]. Although
aspiration-induced pneumonia is well-known in everyday
ICU practice, it should be noted that proving a cause-effect
relationship between dysphagia screening and improved
patient outcomes may be difficult to demonstrate [49, 50].
The MADICU study [45], a web-based survey of members
of the European Society of Intensive Care Medicine (ES-
ICM) and the German Society of Neuro-intensive and
Emergency Medicine (DGNI), reported a high overall
awareness of dysphagia on the ICU even among non-neu-
rointensivists. About 80% perceived dysphagia as a rel-
evant issue. This surprisingly high (according to the au-
thors) percentage may be due to a selection bias, with more
physicians who have a special interest in dysphagia partici-
pating in the survey. One key finding of the MADICU study
is the lack of a standardised diagnostic and instrumental
approach to screening and diagnosing dysphagia outside
of a neurointensive care setting, with only 27.7% of ICU
respondents having specific dysphagia-related protocols in
use. Based on our survey, all participating Swiss ICUs con-
sidered dysphagia a problem in the ICU, with nearly 68%
(25/37) already having a standard operating procedure in
use. This is an even higher proportion than in the neuro-in-
tensive care units which participated in the MADICU sur-
vey (n = 41/69, 60.3%). FEES seemed to be more widely
available for evaluating dysphagia among the units which
participated in the MADICU study, with an overall avail-
ability of 51.1% (n = 268/528), and used more frequently
in both the neuro-intensive care setting (n = 59/69, 85.5%)
and in the general ICU environment (n = 209/459, 45.8%)
than in Switzerland (n = 9/37, 24.3%).
Another study, a nationwide survey of Dutch Intensive
Care Units [46], found a high overall awareness of dyspha-
gia (Likert score ≥4 from 84% of respondents), but found
that only a few ICUs (n = 15/67, 22%) had established
standard operating procedures for dysphagia. Furthermore,
in this Dutch investigation only one unit routinely used
FEES for dysphagia screening, which is in line with the
findings reported here. However, whereas about 60% (40/
67) of ICUs occasionally use FEES in The Netherlands,
this is only rarely implemented on Swiss ICUs.
Over 88,000 ICU patients were admitted to Swiss ICUs
in 2017, with 34% in need of invasive mechanical ven-
tilation (Swiss Society of Intensive Care Medicine [51]).
Given an incidence of post-extubation dysphagia of 12.4%
[9] according to the largest prospective investigation using
a systematic screening approach, approximately 3,700 pa-
tients may have been affected by OD in Switzerland in
2017. Thus, about 340 dysphagia-related deaths (9.2% ex-
cess 90-day mortality rate) may have occurred in Switzer-
land in 2017. This underlines the importance of OD on the
ICU.
We are aware of limitations of this survey, including the
fact that the presented results could theoretically reflect the
opinions of the senior ICU physicians who participated,
and not objectively present patient data (e.g. regarding OD
incidence). In contrast to the MADICU survey, in which it
is most likely that ICU physicians with a special interest in
dysphagia participated, we deliberately aimed to exclude
this potential selection bias. However, although we cannot
rule out a certain bias, a near complete data set of all the
major teaching hospitals is presented in the current inves-
tigation. Furthermore, by nature of the deliberately chosen
approach, a survey can only present the standards of care
current at the time the investigation is performed.
Conclusions
Most Swiss ICUs have established standard operating pro-
cedures for the assessment of dysphagia on the ICU. Se-
quential approaches most often use non-instrumental as-
sessment techniques. Most senior ICU physicians believe
that awareness of dysphagia could be improved. We thus
support the creation of an international expert panel to ad-
dress recommendations for optimal OD screening, confir-
mation and management in critically ill patients on the
ICU.
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Appendix 1
Questionnaire
1 Where are you from?
2 What (ICU) type would best describe your unit?
. Interdisciplinary (Mixed medical/ surgical)
. Mixed medical
. Mixed surgical
. Trauma/ Neurosurgical
. Neurological
. Cardiovascular
. ECMO unit
3 How many total ICU beds?
. 1-6 / 7-12 / 13-18 / 19-24 / 25-30 / >30
4 How many patients do you treat per year on your
ICU?
. < 750 / 751-1500 / 1501-2250 / 2251-3000 / 3001-3750 /
3751-4500 / 4501-5250 / 5251-6000 / >6000
5 Do you generally consider swallowing disorders (dys-
phagia) a problem in your ICU patients?
. yes / no
6 Do you have a standard of care for dysphagia, i.e.
standard operating procedure (SOP) installed for dys-
phagia?
. yes / no / planned in near future
7 Do you routinely screen your ICU patients for dys-
phagia?
. yes, systematic screening of all ICU patients
. yes, screening on individual basis
. no screening performed
. screening planned in near future
8 Which patients do you screen for dysphagia on a rou-
tine basis?
. all ICU patients
. all ICU patients post extubation/ decannulation
. all ICU patients with baseline neurological disease
. all ICU patients with known pre-existing swallowing dis-
order
. all ICU patients with clinical signs for dysphagia (e.g. as-
piration)
9 Based on your screening results/ guess: how many of
your patients have dysphagia during ICU stay?
. 0-10% / 11-20% / 21-30% / 31-40% / 41-50% / 51-60% /
61-70% / 71-80% / 81-90% / 91-100%
10 If performed: who is initially screening for dyspha-
gia on your ICU?
. no screening performed
. screening by trained ICU nurse
. screening by any nurse
. screening by speech language pathologist (SLT)
. screening by physiotherapist (PT)
. screening by an occupational therapist (OT, also ergother-
apist)
. screening by ICU physician
. screening by Ear-Nose-Throat (ENT) physician
. screening by any other physician
11 How do you initially screen for dysphagia on your
ICU?
. test meal
. non-instrumental: water swallow test
. non-instrumental: bedside clinical exam (BSE)
. fibre-endoscopic evaluation of swallowing (FEES)
. videofluorescent swallowing study (VFSS), modified
barium swallow
. manometry
11(a) Who performs FEES at your unit?
. Ear-Nose-Throat (ENT) physician
. ICU physician with FEES accreditation
. ICU physician without FEES accreditation
. other
12 Do you have a sequential approach for dysphagia
testing (screening followed by a specialist assessment)?
. yes / no
13 If a sequential approach is used: who is performing
the specialist exam?
. does not apply: no confirmatory testing performed
. speech-language therapist (SLT)
. physiotherapist (PT)
. occupational therapist (OT, also ergotherapist)
. ICU physician
. Ear-Nose-Throat (ENT) physician
. any other physician
. trained ICU nurse
. any other nurse
14 What technique is used to establish the diagnosis
"dysphagia"?
. clinical evidence for dysphagia (e.g. aspiration)
. clinical exam: bedside swallowing examination (BSE)
. fibre-endoscopic evaluation of swallowing (FEES)
. videofluoroscopic swallowing study (VFSS)
. manometry
14(a) Who performs FEES at your unit?
. Ear-Nose-Throat (ENT) physician
. ICU physician with FEES accreditation
. ICU physician without FEES accreditation
. other
15 How do you treat your ICU patients with dyspha-
gia?
. nil per os during ICU stay
. dietary texture modification
. tube feeding only during ICU stay (oro-/naso-gastric, per-
cutaneous enteral)
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. (early) tracheostomy
. swallowing training: functional therapy for motor/ senso-
motor recovery incl. postural changes (PT/SLT)
. catheter-related electric stimulation
. transcranial magnetic/ electrical stimulation
16 In your opinion, what are major risk factors for de-
veloping dysphagia in ICU patients?
. age of ICU patient
. emergency admission to ICU
. admission to ICU for acute metabolic disorder (e.g. aci-
dosis, electrolyte, or azotemia)
. admission to ICU for acute neurological disease
. admission to ICU for trauma incl. traumatic brain injury
(TBI)
. admission to ICU for sepsis/ septic shock
. pre-existing or (ICU-) acquired muscle wasting/ cachexia
. pre-existing neurological disease
. any oro-/naso-tracheal intubation
. long-term intubation (> 5 days)
. presence of oro- or nasogastric feeding tube
. cumulative amount of sedatives used
. cumulative amount of muscle relaxants used
. cumulative amount of opioids used
. cumulative amount of neurotropic medication (e.g. anti-
convulsives, anti-psychotics, anti-depressants)
17 Do you think that dysphagia diagnosed on the ICU
impacts mid- or long- term mortality (mortality at
>28d)?
. yes / no / undecided
18 Do you think that dysphagia diagnosed on the ICU
prolongs ICU length of stay?
. yes / no / undecided
19 Do you think that dysphagia diagnosed on the ICU
increases total in-hospital treatment costs?
. yes / no / undecided
20 What type of dysphagia related medical complica-
tions do you routinely encounter in your ICU patients?
. no Dysphagia-related complications
. aspiration-induced pneumonia
. sepsis (e.g. due to pneumonia or catheter-related infec-
tions)
. need for ICU re-admission
. need for re-intubation
. need for tracheostomy
. failure for decannulation
. underfeeding / cachexia
21 Should dysphagia awareness be improved in your
ICU?
. yes / no / undecided
22 Do you consider ICU acquired weakness (ICU-AW)
a problem in your patients?
. yes / no / undecided
23 Do you have a standard operating procedure (SOP)
for patients with ICU-AW?
. yes / no / planned to develop in the near future
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Appendix 2 Additional results
ICU responses.
All
(n = 37)
Au+A ICUs
(n = 16)
B+C ICUs
(n = 21)
p-value
n % n % n %
Is dysphagia a problem? Yes 37 100 16 100 21 100
SOP installed? Yes 25 67.6 12 75 13 61.9 0.87
No 9 24.3 3 18.8 6 28.6
Planned 3 8.1 1 6.25 2 9.5
Screening routinely? Yes, all 10 27.0 6 37.5 4 19.0 0.27
Yes, selectively 27 73.0 10 62.5 17 81.0
Estimated OD frequency? 0–10% 4 10.8 1 6.25 3 14.3 0.62
11–20% 11 29.7 5 31.3 6 28.6 0.84
21–30% 11 29.7 4 25 7 33.3 0.72
31–40% 5 13.5 3 18.8 2 9.5 0.63
41–50% 1 2.7 1 4.8 1.00
51–60% 3 8.1 2 12.5 1 4.8 0.57
71–80% 2 5.4 1 6.25 1 4.8 1.00
Sequential approach? Yes 32 86.5 13 81.3 19 90.5 0.63
ICU = intensive care unit; OD = oropharyngeal dysphagia; SOP = standard operating procedure
Original article Swiss Med Wkly. 2019;149:w20111
Swiss Medical Weekly · PDF of the online version · www.smw.ch
Published under the copyright license “Attribution – Non-Commercial – No Derivatives 4.0”.
No commercial reuse without permission. See http://emh.ch/en/services/permissions.html.
Page 10 of 10
